GIP Activation Improved insulin sensitivity, glucose handling, and lipid metabolism the same dual-receptor advantage as tirzepatide
When made according to federal laws, compounded drugs do not require FDA approval and are exempt from undergoing safety, effectiveness, or manufacturing reviews
It does not constitute medical advice, prescribing guidance, or a recommendation for off-label use
The glucagon-like peptide-1 hormone (GLP-1) is produced by your intestines when you eat, and it plays a central role in appetite regulation and blood sugar control
The preventative benefits seem to be facilitated by reduced lipogenesis, increased autophagy, enhanced insulin signalling, and regulation of the FXR/RXR and LXR/RXR pathways (Ma et al
Another study published by Diabetes, Obesity & Metabolism in June 2025 further supported this link, concluding that the five-year risk of developing NAION doubled in patients using GLP-1 drugs compared to non-users